{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:06:41Z","timestamp":1789538801245,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Antidrug Policies Department, Presidency of Italian Council of Ministers"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jpba.2014.06.011","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T14:37:27Z","timestamp":1402929447000},"page":"144-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Liquid chromatography\u2013high resolution mass spectrometry (LC\u2013HRMS) determination of stimulants, anorectic drugs and phosphodiesterase 5 inhibitors (PDE5I) in food supplements"],"prefix":"10.1016","volume":"106","author":[{"given":"Sabina","family":"Strano-Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Odoardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Castrignan\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Serpelloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Chiarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2014.06.011_bib0005","unstructured":"Directive 2002\/46\/EC, http:\/\/ec.europa.eu\/food\/food\/labellingnutrition\/supplements\/index_en.htm (accessed 20.04.14)."},{"key":"10.1016\/j.jpba.2014.06.011_bib0010","unstructured":"Directive 2010\/84\/EU, http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-1\/dir_2010_84\/dir_2010_84_en.pdf (accessed 20.04.14)."},{"key":"10.1016\/j.jpba.2014.06.011_bib0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/bmc.928","article-title":"Clenbuterol marketed as dietary supplement","volume":"22","author":"Parr","year":"2008","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2014.06.011_bib0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.forsciint.2006.02.052","article-title":"Anorectic sibutramine detected in a Chinese herbal drug for weight loss","volume":"161","author":"Jung","year":"2006","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2014.06.011_bib0025","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/01.ftd.0000245392.33305.b0","article-title":"Identification of a sibutramine-metabolite in patient urine after intake of a \u201cpure herbal\u201d Chinese slimming product","volume":"28","author":"Vidal","year":"2006","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2014.06.011_bib0030","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/rcm.2876","article-title":"Detection of sibutramine, its two metabolites and one analogue in a herbal product for weight loss by liquid chromatography triple quadrupole mass spectrometry and time-of-flight mass spectrometry","volume":"21","author":"Zou","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2014.06.011_bib0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/19440049.2014.888497","article-title":"Monitoring of 29 weight loss compounds in foods and dietary supplements by LC\u2013MS\/MS","volume":"31","author":"Kim","year":"2014","journal-title":"Food Addit. Contam. A: Chem. Anal. Control Expo. Risk Assess."},{"key":"10.1016\/j.jpba.2014.06.011_bib0040","series-title":"Biomedical Side Effects of Doping","first-page":"155","article-title":"Nutritional supplements and doping","author":"Delbeke","year":"2001"},{"key":"10.1016\/j.jpba.2014.06.011_bib0045","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/bjsm.2007.037226","article-title":"The continuing story of nutritional supplements and doping infractions","volume":"41","author":"de Hon","year":"2007","journal-title":"Br. J. Sports Med."},{"key":"10.1016\/j.jpba.2014.06.011_bib0050","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1016\/j.chroma.2009.10.016","article-title":"Identification of sildenafil, tadalafil and vardenafil by gas chromatography\u2013mass spectrometry on short capillary column","volume":"1216","author":"Man","year":"2009","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2014.06.011_bib0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.chroma.2013.12.030","article-title":"Application of a high resolution benchtop quadrupole\u2013Orbitrap mass spectrometry for the rapid screening, confirmation and quantification of illegal adulterated phosphodiesterase-5 inhibitors in herbal medicines and dietary supplements","volume":"1344","author":"Shi","year":"2014","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2014.06.011_bib0060","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/19440049.2011.551947","article-title":"A novel approach to simultaneous screening and confirmation of regulated pharmaceutical compounds in dietary supplements by LC\/MS\/MS with an information-dependent acquisition method","volume":"28","author":"Lee","year":"2011","journal-title":"Food Addit. Contam. A: Chem. Anal. Control Expo. Risk Assess."},{"key":"10.1016\/j.jpba.2014.06.011_bib0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jpba.2008.12.002","article-title":"Detection of undeclared erectile dysfunction drugs and analogues in dietary supplements by ion mobility spectrometry","volume":"49","author":"Gryniewicz","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2014.06.011_bib0070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpba.2012.02.014","article-title":"Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: a history, analytical aspects and health risks","volume":"69","author":"Venhuis","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2014.06.011_bib0075","series-title":"List of Prohibited Substances and Methods","author":"Wada","year":"2014"},{"key":"10.1016\/j.jpba.2014.06.011_bib0080","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/02652030601013729","article-title":"Survey of nutritional supplements for selected illegal anabolic steroids and ephedrine using LC-MS\/MS and GC\u2013MS methods, respectively","volume":"24","author":"Martello","year":"2007","journal-title":"Food Addit. Contam."},{"key":"10.1016\/j.jpba.2014.06.011_bib0085","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2013MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2014.06.011_bib0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/11584800-000000000-00000","article-title":"Cardiovascular risk-benefit profile of sibutramine","volume":"10","author":"Scheen","year":"2010","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.jpba.2014.06.011_bib0095","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1093\/eurheartj\/eht266","article-title":"Frequency of drug-induced valvular heart disease in patients previously exposed to benfluorex: a multicentre prospective study","volume":"34","author":"Tribouilloy","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jpba.2014.06.011_bib0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.acvd.2013.02.003","article-title":"Drug-induced valvular heart disease: an update","volume":"106","author":"Andrejak","year":"2013","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.jpba.2014.06.011_bib0105","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708514002994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708514002994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T06:29:44Z","timestamp":1538548184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708514002994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":21,"alternative-id":["S0731708514002994"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2014.06.011","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid chromatography\u2013high resolution mass spectrometry (LC\u2013HRMS) determination of stimulants, anorectic drugs and phosphodiesterase 5 inhibitors (PDE5I) in food supplements","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2014.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}